New York, New York (PRWEB) May 09, 2013
Mirena IUD lawsuits continue to move forward in a federal multidistrict litigation established in U.S. District Court, Southern District of New York, Bernstein Liebhard LLP reports. According to an Order issued on May 3rd, the Court is preparing to consider the appointment of plaintiffs’ attorneys to leadership positions in the litigation. The proceeding’s first Status Conference has been scheduled for May 17th, the Order stated. (In re: Mirena IUD Products Liability Litigation, MDL No. 2434)
“We have heard from numerous women who have allegedly suffered serious Mirena complications, including spontaneous device migration and uterine perforations. We are pleased to see this litigation moving forward, and look forward to more progress in the near future,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free Mirena lawsuit consultations to alleged victims of this birth control device.
The federal Mirena litigation was established by the U.S. Judicial Panel on Multidistrict Litigation via a Transfer Order dated April 8th. When the Transfer Order was issued, more than 40 Mirena IUD lawsuits had already been filed in 17 federal jurisdictions. All of the claims allege the Mirena IUD migrated away from its original position in the uterus, leading to uterine perforations and other serious injuries, which in many cases required risky Mirena removal surgery. Plaintiffs further allege Bayer Healthcare Pharmaceuticals failed to provide adequate warnings regarding the risk of device migration and related Mirena complications.
Dozens of additional Mirena lawsuits have been filed in state courts throughout the country. Court documents indicate Bayer petitioned the New Jersey Supreme Court last year for the establishment of a consolidated litigation in Middlesex County Superior Court for Mirena claims filed in that state. While the request was rejected, plaintiffs in Mirena IUD lawsuits filed in New Jersey petitioned the Court on March 6th to reconsider that request .*
The Mirena IUD was approved by the U.S. Food & Drug Administration (FDA) as a birth control method in 2000. In 2009, Mirena’s approved uses were expanded to include treatment of heavy menstrual bleeding in women who wish to use an IUD as their method of birth control. In December 2009, the FDA issued a warning letter to Bayer after finding that one of its promotional campaigns for the IUD exaggerated the efficacy of the device and minimized potential Mirena complications. Among other things, the FDA took issue with marketing claims touting Mirena’s purported ability to improve a woman’s sex life and help her “look and feel great.”**
Alleged victims of spontaneous device migration leading to uterine perforations or other serious Mirena complications may be entitled to compensation for medical expenses, lost wages, pain and suffering, and more. Learn more about Mirena lawsuits by visiting Bernstein Liebhard LLP’s website. For additional information, please call (877) 779-1414.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
Read the full story at http://www.prweb.com/releases/mirena-lawsuits/mirena-complications/prweb10718178.htm.
Copyright©2012 Vocus, Inc.
All rights reserved